Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals.

European neurology - 1 Jan 2016

Gatto Emilia M, Etcheverry Jose Luis, Sanguinetti Ana, Cesarini Martin, Fernandez Escobar Nicolas, Drelichman Guillermo

Abstract excerpt

Heterozygous mutations in the glucocerebrosidase (GBA) gene have been reported as a common risk factor for the development of Parkinson's disease (PD) in Gaucher disease (GD) patients and in heterozygous GBA mutation positive carriers. In this study, we analyzed the occurrence of prodromal markers of PD in an Argentinean cohort with type 1 GD. After signed informed consent, we evaluated 26 patients with type 1 GD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Enzyme Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gaucher Disease

Share to Glucosylceramidase

Share to Heterozygote

Share to Parkinson Disease

Share to Risk Factors

Share to Young Adult

Source

Identifiers

PMID: 27344356
DOI: 10.1159/000447510

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals.PMID 27344356Read ↗

Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.Semantic proximity Read ↗

Follow up of Pre-motor Symptoms of Parkinson Disease In Adult Patients With Gaucher Disease Type I and Analysis of Their Lysosomal Enzyme Profiles in Cerebrospinal FluidSemantic proximity Read ↗

Evolution of prodromal parkinsonian features in a cohort ofGBAmutation-positive individuals: a 6-year longitudinal studySemantic proximity Read ↗

GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic ApproachesSemantic proximity Read ↗

A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk.Semantic proximity Read ↗

Exploring the Genotype–Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential ModifiersSemantic proximity Read ↗

Cognitive decline and depressive symptoms: early non-motor presentations of parkinsonism among Egyptian Gaucher patients.Semantic proximity Read ↗

Gaucher disease provides a unique window into Parkinson disease pathogenesis.Semantic proximity Read ↗

The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.Semantic proximity Read ↗

Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations.Semantic proximity Read ↗

Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.Semantic proximity Read ↗

Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.